You can’t read much about the venture capital industry before you start hearing about the so-called “valley of death” for early stage companies.Conventional wisdom holds that young companies enter that valley, in which attracting investment capital becomes extremely difficult, at an early stage, typically between an initial round of angel funding and the company’s first [...]

When we last heard from Foundation Radiology Group, the radiology outsourcing company had raised $1 million last November, funding that was revealed in a regulatory document.Now the company has filed an amended regulatory document with the U.S. Securities and Exchange Commission that indicates it’s raised another $1 million.AdvertisementThat’s consistent with Pittsburgh-based Foundation’s practices of not [...]

Cytomedix‘s (OTC:CMXI) Aldagen acquisition signaled the company’s intention to establish a strong presence in regenerative medicine therapies and the deal fills needs for both companies. Aldagen, who had tried twice to go public only to withdraw both times amid poor market conditions, gets a partner interested in developing its stem cell treatments. Cytomedix gains prospective [...]

Watson Pharmaceuticals (NYSE:WPI) wants to add a branded drugs focus alongside its generics business and is setting aside $6 billion for acquisitions to do it, according to a report by Bloomberg.Chief executive officer Paul Bisaro said: “Everything we need to be a branded pharma company we have, except for the sales force. … And we [...]

Celgene (NYSE:CELG) has made a $15 million strategic investment in a cancer drug developer, which gives it a seat on the company’s board and opens up collaboration opportunities down the road.Acetylon Pharmaceuticals uses histone deacetylase or HDAC inhibitors to develop small molecule cancer treatmentsas well as treatments for autoimmune and other diseases. The lead drug [...]

Regenerative medicine company Cytomedix (OTC:CMXI) has acquired North Carolina stem cell technology company Aldagen in a stock deal valued at $40 million that broadens the firm’s regenerative therapies pipeline.Maryland-based Cytomedix develops biologically active regenerative therapies for wound care, inflammation and blood vessel development. The company has been diversifying to build its regenerative medicine capabilities. Aldagen’s [...]

Raising money for a medical device startup can be incredibly challenging, but serial entrepreneur Michael Berman financed his latest venture MikrobEX in a rather clever fashion.He wanted to raise $5 million and also take advantage of the Minnesota Angel Investment Tax Credit program. But the angel program puts a cap on the amount of money [...]

An HIV/AIDS treatment developed by GlaxoSmithKline (NYSE:GSK) is now being studied with Siemens (NYSE:SI) to develop companion diagnostics that doctors can use to select patients appropriate for the treatment.The partnership with ViiV Healthcare, GSK’s AIDS drug joint venture with Pfizer (NYSE:PFE), will study the drug Selzentry in a phase 3 study comparing it to another [...]

The chief executive of what was touted as a $100 million investment fund aimed in part at Ohio medical device companies has been indicted for his alleged role in the failure of a suburban Cleveland credit union.The indictment of 43-year-old businessman Eddy Zai, who was charged with 34 counts related to more than $16 million [...]

There’s a new angel investment fund in North Carolina’s Research Triangle with capital to feed early stage life science and technology companies.Triangle Angel Partners, or TAP, has formed with participation from more than 40 investors in the Triangle and raised $2.3 million, WRALTechWire reports. Financial backers include Rich Lee, the former CEO of data center [...]